Provided by Tiger Trade Technology Pte. Ltd.

Invesco KBW Premium Yield Equity REIT ETF

16.54
+0.05140.31%
Post-market: 16.540.00000.00%19:50 EDT
Volume:255.81K
Turnover:4.24M
Market Cap:297.39M
PE:- -
High:16.74
Open:16.64
Low:16.48
Close:16.49
52wk High:19.35
52wk Low:14.82
Shares:17.98M
Float Shares:17.98M
Volume Ratio:0.82
T/O Rate:1.42%
Dividend:1.48
Dividend Rate:8.94%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Innovative Industrial Properties (IIPR) Stock May Be 49% Undervalued Despite 52 Week High

Simply Wall St.
·
Jul 17

Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins

GlobeNewswire
·
Jul 16

JLL Reports Sustained Recovery in Shanghai Commercial Property Leasing and Increased Investment Activity

Deep News
·
Jul 15

Gladstone Commercial initiated with a Market Perform at Huntington

TIPRANKS
·
Jul 15

Gladstone Commercial Publishes Financial Calendar Update

Reuters
·
Jul 15

Gladstone Commercial Declares USD 0.10 Monthly Common Distribution for July-september 2026

Reuters
·
Jul 15

Three Landmark Projects Simultaneously Break Ground, Signaling Recovery Momentum in Manhattan Commercial Real Estate

Deep News
·
Jul 13

LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026

GlobeNewswire
·
Jul 12

Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress

GlobeNewswire
·
Jul 12

Peapack Private Appoints Paul Kotronis as Senior Managing Director, Commercial Real Estate

GlobeNewswire
·
Jul 11

JLL: Beijing Office Market Enters Phase of Systemic Restructuring

Deep News
·
Jul 10

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

GlobeNewswire
·
Jul 08

MERLIN Properties Sets Date for H1 2026 Results and Investor Call

TIPRANKS
·
Jul 07

U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

GlobeNewswire
·
Jul 07

Makkah Construction Signs Contract with Roots Innovative Industrial

Reuters
·
Jul 07